Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 503-505

  Carratala, Jordi ^a   Fernandez Sevilla, Alberto ^a   Tubau, Fe ^a   Angeles Dominguez, M ^a   Gudiol, Francesc ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NORFLOXACIN; NYSTATIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANDIDA KRUSEI; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DOSE RESPONSE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; LYMPHOMA; MALE; MULTIPLE MYELOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS MITIS;

EID: 0030067792     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.503     Document Type: Article

References (28)

1. Barret, T. J., H. Lior, J. H. Gree, R. Khakhria, J. G. Wells, B. P. Bell, K. D. Greene, J. Lewis, and P. M. Griffin. 1994 Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing J. Clin. Microbiol. 32:3013-3017.
2. Bodey, G. P. 1988. Antimicrobial prophylaxis for infection in neutropenic patients, p. 1-43. In J. S. Remington and M. N Swartz (ed.). Current clinical topics in infectious diseases, vol. 9. McGraw-Hill. New York.
3. Bow, E. J., R. Loewen, and D. Vaughan. 1995. Reduced requirement for antibiotic therapy targeting gram-negative organisms in febrile, neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones. Clin Infect. Dis. 20:907-912.
4. Bow, E. J., E. Rayner, and T. J. Louie. 1988. Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia The trade-off for reduced gram-negative sepsis. Am. J. Med. 84:847-854
5. Bow, E. J., and A. R. Ronald. 1993 Antibacterial chemoprophylaxis in neutropenic patients - where do we go from here? Clin. Infect. Dis. 17:333-337. (Editorial.)
6. Carratala, J., A. Fernandez-Sevilla, F. Tubau, M. Callis, and F. Gudiol. 1995. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin. Infect. Dis 20:557-560
7. Classen, D. C., J. P. Burke, C. D. Ford, S. Evershed, M. R. Aloia, and J. K. Wilfahrt. 1990. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am. J Med. 89:441-446.
8. Cometta, A., T. Calandra, J. Bille, and M. P. Glauser. 1994. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N. Engl. J Med. 330:1240-1241. (Letter.)
9. Donnelly, J. P., G. Maschmeyer, and S. Daenen. 1992. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia. Ciprofloxacin versus co-trimoxazole plus colistin. Eur. J. Cancer 28A:873-878.
10. Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect. Dis. 14:1201-1207.
11. Giuliano, M., A. Pantosti, G. Gentile, M. Venditti, W. Arcese, and P. Martino. 1989. Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients. Antimicrob. Agents Chemother. 33:1709-1713
12. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto Infection Program. 1991. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Ann. Intern. Med 115:7-12.
13. Gualtieri, R. J., G. R. Donowitz, D. L. Kaiser, C. E. Hess, and M. A. Sande. 1983. Double-blind randomized study of prophylactic trimethoprim-sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am. J Med. 74:934-940.
14. Jansen, J., M. Cromer, L. Akard, J. R. Black, L. J. Wheat, and S. D. Allen. 1994. Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. Am. J. Med 96:335-341.
15. Karp, J. E., W. G. Merz, C. Hendricksen, B. Laughon, T. Redden, B. J. Bamberger, J. G. Bartlett, R. Saral, and P. J. Burke. 1987. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 106:1-7.
16. Kern, W. V., E. Andriof, M. Oethinger, P. Kern, J. Hacker, and R. Marre. 1994 Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 38:681-687.
17. Lew, M. A., K. Kehoe, J. Ritz, K. H. Antman, L. Nadler, L. A. Kalish, and R. Finberg. 1995. Ciprofloxacin versus trimethroprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J. Clin. Oncol. 13:239-250
18. Liang, R. H. S., R. W. H. Yung, T. Chan, P. Chau, W. Lam, S. So, and D. Todd. 1990. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Antimicrob. Agents Chemother. 34:215-218.
19. Murray, B. E., E. R. Rensimer, and H. L. DuPont. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl J. Med 306:130-135.
20. National Committee for Clinical Laboratory Standards. 1990. Performance standard for antimicrobial disk susceptibility test. Approved standard M2-A4. National Committee for Clinical Laboratory Standards, Villanova. Pa.
21. Peña, C., J. M. Albareda, R. Pallares, M. Pujol, F. Tubau, and J. Ariza. 1995. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections Antimicrob. Agents Chemother 39:520-524.
22. Rozenberg-Arska, M., A. W. Dekker, and J. Verhoef. 1985 Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J. Infect. Dis 152:104-107.
23. Talbot, G. H., P. A. Cassileth, L. Paradiso, R. Correa-Coronas, L. Bond, and the Enoxacin Prophylaxis Study Group. 1993 Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. Antimicrob Agents Chemother. 37:474-182.
24. Tancrède, C. H., and A. O. Andremont. 1985 Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J. Infect. Dis. 152:99-103.
25. Van de Leur, J. J. J. P. M., E. J. Vollaard, A. J. H. M. Janssen, and A. S. M. Dofferhoff. 1995. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients. Antimicrob. Agents Chemother. 39:1182-1184.
26. Wade, J. C., S. C. Schimpff, M. T. Hargadon, C. L. Fortner, V. M. Young, and P. H. Wiernik. 1981. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N. Engl. J Med. 304:1057-1062
27. Ward, T. T., R. G. Thomas, C. L. Fye, R. Arbeit, C. A. Coltman, Jr., W. Craig, B. W. Dana, S. M. Finegold, J. Lentino, R. L. Penn, J. B. Weinberg, B. Chow, S. Ochi, and participating investigators. 1993. Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia, evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs cooperative study. Clin. Infect. Dis. 17:323-332
28. Winston, D. J., W. G. Ho, D. A. Bruckner, R. P. Gale, and R. E. Champlin. 1990 Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am. J. Med. 88:36-42.